Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7401974

Cc1cc(COc2ccc(C(N)=O)cc2)c2ccccc2n1.O=C(O)C(F)(F)F

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ADAM17 P78536 5/20 0.56
MMP2 P08253 3/20 0.55
MMP12 P39900 2/20 0.55
PARP10 Q53GL7 1/20 0.54
MMP3 P08254 1/20 0.54
MAOB P27338 1/20 0.53
MMP13 P45452 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1504829 0.93 ADAM17 (0.61) ADAM17MMP2MMP12PARP10MMP3
SCHEMBL1504715 0.84 ADAM17 (0.64) ADAM17MMP2MMP12MMP3MMP13
Trifluoroacetic Acid SCHEMBL6597004 0.83 MEN1 (0.54) ADAM17MMP3MMP13
SCHEMBL3968177 0.82 ADAM17 (0.61) ADAM17MMP2MMP12MMP3MMP13
SCHEMBL6212594 0.81 ADAM17 (0.63) ADAM17MMP2MMP12MMP3
Hydrochloric Acid SCHEMBL4053797 0.81 ADAM17 (0.60) ADAM17MMP2MMP12MMP13
Trifluoroacetic Acid SCHEMBL6600731 0.79 ADAM17 (0.69) ADAM17MMP2MMP12MMP3
Trifluoroacetic Acid SCHEMBL6597682 0.79 ADAM17 (0.69) ADAM17MMP2MMP12MMP3
Trifluoroacetic Acid SCHEMBL6597417 0.79 ADAM17 (0.57) ADAM17MMP2MMP12
Trifluoroacetic Acid SCHEMBL6597459 0.79 ADAM17 (0.57) ADAM17MMP2MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1263756-A2 BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA Bristol-Myers Squibb Pharma Company (US) 2002-12-11 EP disclosed
WO-2001070734-A2 BETA-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-ALPHA BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2001-09-27 WO disclosed